Vancomycin-resistant Staphylococcus aureus: Difference between revisions
Hardik Patel (talk | contribs) |
m Changes made per Mahshid's request |
||
| Line 50: | Line 50: | ||
[[Category:Bacterial diseases]] | [[Category:Bacterial diseases]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
Latest revision as of 19:06, 18 September 2017
For patient information click here
|
Vancomycin-resistant Staphylococcus aureus Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Vancomycin-resistant Staphylococcus aureus On the Web |
|
American Roentgen Ray Society Images of Vancomycin-resistant Staphylococcus aureus |
|
Directions to Hospitals Treating Vancomycin-resistant Staphylococcus aureus |
|
Risk calculators and risk factors for Vancomycin-resistant Staphylococcus aureus |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: VRSA; VISA; vancomycin-intermediate Staphylococcus aureus
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies